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ToxicologyUsnic acid is a naturally occurring dibenzofuran derivative found in several lichen species. The compound 
has been marketed as an ingredient of food supplements for weight reduction. There is evidence that the 
comp ound acts as an uncouple r of mitochondrial oxidati ve phosphorylation and it is also clear that con- 
sumption of the drug can lead to severe hepatotoxicity depending on the doses. Based on these and other 
ideas the objective of the present work was to investigate the possibl e effects of usnic acid on liver 
metaboli sm. Livers of male Wistar rats were perfused in a non-recirc ulating system. Usnic acid stimu- 
lated oxygen consumption at low concentrations, diminished the cellular ATP levels, increased the cyto- 
solic but diminished the mitochondrial NADH/NAD + ratio, strongly inhibite d gluconeoge nesis from three 
different substrates (IC50 between 1.33 and 3.61 lM), stimulated glycolysis, fructolysis, glycogenolysis 
and ammoniagenesis and inhibited ureogenesis. The 14CO2 production from [1- 
14C]octanoate and 
[1-14C]oleate was increased by usnic acid, but ketogenesis from octanoate was diminished and that from 
oleate was not affected. It may be concluded that the effects of usnic acid up to 2.5 lM reﬂect predom- 
inantly its activity as an uncouple r. At higher concentrations, however, several other effects may become 
signiﬁcant, including inhibition of mitochondrial electron ﬂow and inhibition of medium-chain fatty acid 
oxidatio n. In metabolic terms, toxicity of usnic acid can be predicted to be espec ially dangerous in the 
fasted state due to the combination of several deleterius events such as diminished hepatic glucose 
and ketone bodies output to the brain and increased ammonia produc tion. 
 2013 Elsevier Ireland Ltd. Open access under the Elsevier OA license. 1. Introduction 
Uncouplers of mitochondr ial oxidative phosphorylatio n have 
always been investigated as possible ingredients for weight-loss 
supplements because they are associated with increased metaboli c
rates and stimulated fuel oxidation. The uncoupler 2,4-dinitrophe- 
nol was indeed used for this purpose for some time [1]. Its use was 
discontinue d, however, due to a number of toxic effects [1,2]. Usnic 
acid (2,6-diacetyl-7,9-dihydroxy-8,9b- dimethyl-1,3[2 H,9bH]-dib- 
enzofurandion e) is another mitochondrial uncoupler that has been 
investigated and marketed as an ingredient in dietary supplements 
for weight reduction , but it has also been associate d with serious 
side-effects, mainly hepatotoxicity and acute liver failure [3,4]. Us- 
nic acid is a dibenzofuran derivative that occurs as a secondary 
metabolite in several lichen species. Its chemical structure is 
shown in Fig. 1. It has been claimed that in addition to its weight 
reducing effects usnic acid has also antibiotic, antiviral, antiproto- 
zoal, antiproli ferative, anti-inﬂammatory and analgesic activities. 
All these activities are said to be linked to the uncoupling proper- 
ties of the compound [5,6]. It can exist naturally as the (+) and ()enantiomer , but most of its biological activity is attributed to the 
(+) enantiomer. The latter has been included as an ingredient of 
cosmetic s, which are used as both active principle and preservative 
[5,7].
The uncoupling effect of usnic acid was ﬁrst demonst rated in rat 
liver homogenates and mitochondria [8,9] and subsequent ly con- 
ﬁrmed in isolated mouse liver mitochondria [10]. The uncoupling 
action of usnic acid in mouse liver mitochondria presents the same 
features as those of 2,4-dinitrophenol : impairment of respiratory 
control, stimulation of the oligomycin- sensitive respiration, inhibi- 
tion of ATP synthesis and stimulati on of the Mg +2-ATPase [10].
Similarly to 2,4-dinitrop henol, usnic acid is considered to be a pro- 
tonophori c uncoupler. However, usnic acid is 50 times more potent 
than 2,4-dinitrop henol, with maximal uncoupling at 1 lM,
whereas 50 lM 2,4-dinitrop henol is required to reach a compara -
ble degree of uncoupling. 
It has been suggested that the hepatotoxici ty of usnic acid is re- 
lated primarily to its uncoupling action [4,10–12]. It has also been 
suggested that the compound might cause inhibition of the 
mitochond rial electron transport chain [4,11,13]. The viability of 
cultured hepatocytes, which is an indicative of hepatotoxici ty, 
was strongly reduced when the oxidative phospho rylation was 
inhibited by usnic acid as indicated by the reduction in the ATP lev- 
els [13]. In cultured mouse hepatocytes the inhibition of oxidative 
Fig. 1. Structural formula of usnic acid. 
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sis was also found in the liver of mice that were treated with usnic 
acid [14,15]. In addition, hepatocytes and isolated mitochondria 
from livers of both mice and rats exposed to usnic acid showed in- 
creased levels of reactive oxygen species, diminution of reduced 
glutathione (GSH) in addition to necrotic and apoptotic changes, 
suggesting a role for oxidative stress in the hepatotoxicity 
[4,12,15]. In humans, hepatotoxici ty of usnic acid has been the sub- 
ject of several reports including cases of acute liver failure and 
necessity of liver transplanta tion [3,16,17].
The most obvious consequence of the uncoupling action of us- 
nic acid is ATP depletion, as indeed demonstrat ed in two studies 
using rat hepatocytes [12,13]. However, this phenomenon is prob- 
ably linked directly or indirectly to a variety of modiﬁcations in 
metabolic ﬂuxes [18–21]. Although the toxic manifestations at 
the cellular level have been more extensively investigated [12,13]
little information is available about the action of usnic acid on spe- 
ciﬁc metaboli c pathways. An attempt of approaching this question 
has been made using [13C]glucose tracer and cultured hepatocytes 
[13]. Roughly speaking the data that were obtained in this study 
indicate what one can normally expect from an uncoupler: stimu- 
lation of catabolic pathways and inhibition of anabolic ones. A pre- 
cise quantiﬁcation of speciﬁc metabolic pathways under the 
inﬂuence of usnic acid, however , is still not available . A meaningful 
evaluation of speciﬁc metaboli c pathways is best made in the iso- 
lated perfused rat liver, a system in which true metabolic steady 
states can be established under conditions that are much closer 
to the physiological situation than isolated and cultured cells 
[22]. The present study, thus, takes advantag e of the perfused liver 
for quantifying the metaboli c effects of usnic acid on both catabolic 
and anabolic pathways under various condition s. The results 
should improve understa nding of the metaboli c effects of usnic 
acid and also allow to compare the action of this compound with 
that of other drugs. The results should also provide an answer to 
the question of how adequate it is to use usnic acid for weight-lo s- 
ing purposes. 
2. Materials and methods 
2.1. Materials 
The liver perfusion apparatus was built in the workshops of the 
University of Maringá. Enzymes and coenzymes used in the enzy- 
matic assays were purchased from Sigma–Aldrich (St. Louis, MO, 
USA). [1- 14C]Octanoic acid (O-7012, speciﬁc activity 53 mCi/mmol)
was purchased from Sigma–Aldrich (St. Louis, MO, USA).
[1-14C]Oleic acid (NEC317050UC, speciﬁc activity 54.4 mCi/mmol)
was purchased from Perkin–Elmer (Boston, MA, USA). All standard 
chemicals were of the best available grade. 
2.2. Animals 
Male albino rats (Wistar), weighing 180–220 g, were fed ad libi- 
tum with a standard laborator y diet (Nuvilab, Colombo, Brazil). In 
several experimental protocols, the rats were starved for 18 hbefore the surgical removal of the liver. All experiments were done 
in accordance with the internationally accepted recomme ndations 
in the care and use of animals. 2.3. Liver perfusion 
For the surgical procedure, the rats were anesthetize d by intra- 
peritonea l injection of thiopental (50 mg/kg). The criterion of anes- 
thesia was the lack of body or limb movement in response to a
standardi zed tail clamping stimulus. Hemoglobin-fr ee, non-recir- 
culating perfusion was performed [22]. After cannulation of the 
portal and cava veins, the liver was positioned in a plexiglass 
chamber. The perfusion ﬂuid was Krebs/Henselei t-bicarbonate 
buffer (pH 7.4), saturated with a mixture of oxygen and carbon 
dioxide (95:5) by means of a membrane oxygenator with simulta- 
neous temperature adjustment at 37 C. The ﬂow, provided by a
peristaltic pump, was between 30 and 33 mL/min. Usnic acid was 
infused into the perfusion ﬂuid as a dimethylfor mamide solution 
by means of a precision pump. The rate of infusion was the same 
in all experiments , namely 10 lL/min. The concentratio n of usnic 
acid in the dimethyl formamide solution was adjusted in such a
way as to ensure the ﬁnal perfusate concentrations of 1, 2.5, 5, 
and 10 lM. With an infusion rate of 10 lL/min the ratio (di-
methyl-form amide)/(Krebs/Henseleit-bica rbonate buffer) was very 
low, between 3.03  10–4 and 3.3  10–4. Control experiments 
have shown that this proportion of dimethyl formamide does not 
affect the metabolic rates measured in the present work nor does 
it affect liver viability as can be judged from its oxygen uptake 
rates and perfusion ﬂuid leakage. Substrates (lactate, fructose, ala- 
nine, [1- 14C]octanoate and [1- 14C]oleate) were dissolved directly 
into the Krebs/Hense- leit-bicarbonat e buffer at the desired 
concentr ation. 2.4. Analytics 
Samples of the efﬂuent perfusion ﬂuid were collected according 
to the experimental protocol and analyzed for their metabolite 
contents . The following compounds were assayed by means of 
standard enzymatic procedures: glucose, lactate, pyruvate, urea, 
ammonia and L-glutama te [23]. The oxygen concentratio n in the 
outﬂowing perfusate was monitored continuously , employin g a
Teﬂon-shielded platinum electrode adequately positioned in a
plexiglass chamber at the exit of the perfusate [24]. Metabolic rates 
were calculated from input–output differences and the total ﬂow
rates and were referred to the wet weight of the liver. 
In those experiments in which [1- 14C]octano ate or [1- 14C]oleate
were infused for measuring 14CO2 production the outﬂowing per- 
fusate was collected in Erlenmeyer ﬂasks in 2-min fractions. The 
Erlenmeyer ﬂasks were rapidly and tightly closed with rubber 
stoppers to which scintillation vials containing phenylethylam ine 
were fastened by means of stainless steel wires. Trapping of the 
14CO2 in phenylethylami ne was accomplished by acidiﬁcation of 
the perfusate with a HCl solution which was injected into the ﬂasks
through the rubber stoppers. Radioact ivity was measured by liquid 
scintillat ion spectroscopy. The scintillation solution was: toluene/ 
ethanol (2/1) containing 5 g/l 2,5-diphenylox azole and 0.15 g/l 
2,2-p-phenyl ene-bis(5-phenyloxazole). The rate of 14CO2 produc-
tion was calculated from the speciﬁc activity of each labeled fatty 
acid and from the rate of radioactivity infusion. 
The hepatic contents of adenine nucleotides were measured 
after freeze-clamping the perfused livers with liquid nitrogen 
[25]. The freeze-clamped livers were extracted with perchloric 
acid. The extract was neutraliz ed with K2CO3 and AMP, ADP, and 
ATP were assayed by means of standard enzymatic procedures 
[23].
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The metabolic rates were expressed as lmol per minute per 
gram liver wet weight (lmol min 1 g1). Statistical analysis of 
the data was done by means of the Statistica ™ program (Statsoft,
1998). The results are mentioned in the tables as the p values.3. Results 
3.1. Effects of usnic acid on glycogen catabolism and glycolysis 
As a ﬁrst approach experime nts were planned in order to test 
possible effects of usnic acid on glycogen catabolis m and glycoly- 
sis. Livers from fed rats when perfused with substrate-free medium 
survive at the expense of glycogen degradat ion via glycolysis and 
oxidation of endogen ous fatty acids [22]. Under these conditions 
the livers release glucose, lactate and pyruvate as a result of glyco- 
gen catabolism. The results of experiments in which the actions of 
four usnic acid concentrations (1, 2.5, 5, and 10 lM) were investi- 
gated are summarized in Fig. 2. Panel A illustrates the time course 
of the action of 10 lM usnic acid. It also illustrate s the experimen- 
tal protocol that was used for all other usnic acid concentratio ns. 
After a pre-perfusion period of 10 min, usnic acid was infused dur- 
ing 30 min, followed by additional 20 min of drug-free perfusion. 
Four paramete rs were measured: glucose release, lactate and pyru- 
vate productions and oxygen consump tion. Panel A of Fig. 2 shows
that all paramete rs were relatively stable before usnic acid A
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Fig. 2. Effects of usnic acid on glycogen catabolism and endogenous fatty acids-driven
substrate-free perfusion ﬂuid as described in the Section 2. Samples of the efﬂuent perfu
was monitored polarographically. Panel A: time course of the effects of 10 lM usnic acid
acid after 30 min infusion (40 min perfusion time). Glycogenolysis means glucose p
production. Each datum point represents the mean of four liver perfusion experiments.infusion. The introduction of the drug changed all parameters after 
a short period of approximat ely 4 min. Glucose, lactate and pyru- 
vate productions increased progressively during the ﬁrst 20 min 
and remained elevated up to the point at which the usnic acid infu- 
sion was discontinue d. Oxygen uptake also increased, reached a
maximum at 20–24 min and decreased progressive ly. At the end 
of the usnic acid infusion period (40 min perfusion time), however, 
the rate of oxygen uptake was still above the rate observed before 
the onset of the infusion. Cessation of the infusion of usnic acid at 
40 min perfusion time caused the reversal of all stimulations ex- 
cept that of oxygen uptake. In panel B of Fig. 2 the stimulati ons 
caused by usnic acid were represented against the concentratio ns 
of the drug. For this analysis the data were recalculated in terms 
of glycolysis (lactate + pyruvate production) and glycogenoly sis 
(glucose release + ½[lactate + pyruvate production]). These calcu- 
lations provide good approximat ions for the metabolic pathways 
due to the low ﬂux through the pyruvate dehydrogen ase under 
the speciﬁc perfusion conditions. It should be remarked that 
Fig. 2B shows the incremen ts in glycolysis and glycogenoly sis, 
i.e., the differences between the rates found in the presence of us- 
nic acid and the rates found before the onset of usnic acid infusion. 
The points of maximal increment by usnic acid were taken for the 
calculatio ns. For all parameters except oxygen uptake the maximal 
incremen t was always found at 30 min usnic acid infusion (40 min 
perfusion time). In the case of oxygen uptake the maximal incre- 
ment was found at this time only for concentrations up to 
2.5 lM; for the concentratio ns of 5 and 10 lM the maximal incre- 
ment occurred earlier in time (see Fig. 2A). Panel B of Fig. 2 alsoB
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sion ﬂuid were collected for the enzymatic metabolite assay. Oxygen consumption 
; panel B: concentration dependence of the changes (increases) promoted by usnic 
roduction + ½(lactate + pyruvate production); glycolysis means lactate + pyruvate 
 Bars are standard errors of the mean. 
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concentratio n. This parameter is an indicator for the cytosolic 
NADH/NAD+ ratio [22]. Excepting oxygen uptake, all calculated 
parameters increased almost linearly with the usnic acid concen- 
tration, i.e., no saturatio n was apparent for usnic acid up to 
10 lM. For oxygen uptake a clear maximum at 2.5 lM usnic acid 
was found, with less pronounced stimulati ons at the concentra- 
tions of 5 and 10 lM.
3.2. Effects of usnic acid on lactate gluconeogen esis and associated 
variables
Fig. 3 shows results of experiments in which the action of usnic 
acid on lactate gluconeogenes is and associated parameters was 
measured. Livers from 18 h fasted rats were used in order to min- 
imize interference by glycogen catabolis m. Fig. 3A illustrates the 
response of the perfused liver to usnic acid infusion at the concen- 
tration of 10 lM and also illustrates the experimental protocol. 
After a pre-perfusion period of 10 min in the absence of substrate ,
2 mM lactate was infused during 30 min, followed by additional 
30 min of usnic acid plus lactate infusion. In the absence of usnic 
acid the infusion of 2 mM lactate produced rapid and sustained in- 
creases in glucose production, oxygen uptake and pyruvate pro- 
duction. The infusion of 10 lM usnic acid caused a progressive 
and, at the end, almost complete inhibition of glucose production. 
Only a slight recovery occurred during the 10 min following cessa- 
tion of the drug infusion. Oxygen consumptio n was stimulated ini- 
tially by usnic acid. This stimulati on was not stable, however, as it 
declined progressive ly and was minimal at the end of the infusion. 
Pyruvate production was also stimulated by usnic acid, but stimu- 
lation was not stable. Analysis of the concentr ation dependence is 
allowed by Fig. 3B. Here again the variables represented against 
the usnic acid concentration correspond to the maximal changes 
caused by the drug. If the changes were stable (glucose production A
Fig. 3. Effects of usnic acid on lactate gluconeogenesis and associated variables in the pe
Lactate was infused during 70 min (10–80 min perfusion time). Samples of the efﬂu
consumption was monitored polarographically. Panel A: time course of the effects of 10
panel B: concentration dependence of the changes promoted by usnic acid after 30 min in
perfusion experiments. Bars are standard errors of the mean. or oxygen uptake for concentr ations up to 2.5 lM) they correspond 
to the values found at 70 min perfusion time (30 min usnic acid 
infusion). If the changes were not stable (e.g., oxygen uptake for us- 
nic acid concentr ations above 2.5 lM), the peak increments were 
represented. Inhibition is evidenced by the negative values on 
the scale. Inhibition of glucose production was already evident at 
1 lM usnic acid and practicall y maximal at concentr ations above 
2.5 lM. Numerical interpolation revealed that 50% of maximal 
inhibition can be expected at an usnic acid concentr ation of 
1.33 lM. Pyruvate production was slightly increased by usnic acid 
without a deﬁned concentratio n dependence. Oxygen uptake was 
maximal ly stimulated at 2.5 lM usnic acid. 
3.3. Effects of usnic acid on fructose metabolis m
Transforma tion of fructose in the liver allows the simultaneous 
monitoring of anabolic and catabolic reactions, as this substrate 
can be transformed into glucose via an energy-requ iring pathway 
and into lactate or pyruvate via an energy-yielding route. The re- 
sults of the experiments that were done in the present study are 
summari zed in Fig. 4. Here again livers from 18 h fasted rats were 
used in order to minimize interference by glycogen catabolis m. As 
expected , the infusion of fructose produced rapid and quite pro- 
nounced incremen ts in glucose, lactate and pyruvate productions 
and oxygen uptake (Fig. 4A). The subsequent introduction of 
10 lM usnic acid caused a marked decrease in glucose production, 
transient stimulations in lactate and pyruvate productions and a
relatively small transient increase in oxygen uptake. At the usnic 
acid concentratio ns of 1 and 2.5 lM, the increments in lactate 
and pyruvate productions and oxygen uptake were stable (not
shown). The concentration depende nces of the effects are shown 
in Fig. 4B. The inhibition of glucose production is a clear function 
of the usnic acid concentration. Numerical interpolation predicts 
50% inhibition at an usnic acid concentratio n of 1.72 lM. Lactate B
rfused rat liver. Livers from fasted rats were perfused as described in the Section 2.
ent perfusion ﬂuid were collected for the enzymatic metabolite assay. Oxygen 
 lM usnic acid, which was infused during 30 min (40–70 min perfusion time) and 
fusion (70 min perfusion time). Each datum point represents the mean of four liver 
A B
Fig. 4. Effects of usnic acid on fructose metabolism in the perfused rat liver. Livers from fasted rats were perfused as described in the Section 2. Fructose was infused during 
60 min (10–70 min perfusion time). Samples of the efﬂuent perfusion ﬂuid were collected for the enzymatic metabolite assay. Oxygen consumption was monitored 
polarographically. Panel A: time course of the effects of 10 lM usnic acid, which was infused during 30 min (30–60 min perfusion time) and panel B: concentration 
dependence of the changes promoted by usnic acid after 30 min infusion (60 min perfusion time). Each datum point represents the mean of four liver perfusion experiments. 
Bars are standard errors of the mean. 
506 C.T. Moreira et al. / Chemico-Biological Interactions 203 (2013) 502–511production ceased to increase at usnic acid concentratio ns higher 
than 2.5 lM. Pyruvate production and oxygen uptake stimulations 
showed poorly deﬁned concentration dependences, but the overall 
effect was stimulation, even though it might have been transient in 
nature.
3.4. Effects of usnic acid on alanine metabolis m
When used as a substrate alanine allows to measure both car- 
bon and nitrogen ﬂuxes in the liver. Experiments were thus 
planned with alanine in order to see how usnic acid affects vari- 
ables linked to carbon and nitrogen metabolism. Livers from 18 h
fasted rats were used. The time courses of the experiments that 
were done with 10 lM usnic acid can be seen in Fig. 5: panel A
shows carbon ﬂuxes e panel B the simultaneous nitrogen ﬂuxes.
The introduct ion of alanine produced stable increments in oxygen 
uptake, glucose, lactate and pyruvate productions (panel A) and 
urea, ammonia and L-glutamate productions (panel B). Glucose, 
urea and L-glutamate productions were clearly inhibited by 
10 lM usnic acid. Ammonia production, on the other hand, was 
clearly increased, the same what occurred with pyruvate produc- 
tion. Oxygen uptake and lactate production experienced initial in- 
creases which were subsequently reversed or even turned into 
inhibition. Similar results were obtained with lower usnic acid 
concentratio ns, except that lactate production and oxygen uptake 
experienced stable rather than transitory incremen ts at the con- 
centrations of 1 and 2.5 lM. Fig. 6 shows the concentration depen- 
dences of the changes caused by usnic acid. Clearly deﬁnedconcentr ation dependences were found for pyruvate production 
(stimulation, no saturation), glucose production (50% inhibition 
at 3.61 lM), ammonia production (stimulation; 50% of maximal ef- 
fect at 1.92 lM) and urea production (50% inhibition at 2.69 lM).
The inhibition of L-glutamate production was similar for all con- 
centrations ; the same can be said about the stimulation of lactate 
production. Oxygen uptake was stimulated by usnic acid concen- 
trations up to 2.5 lM; at higher concentratio ns stimulati on was 
practicall y absent. 
3.5. Effects of usnic acid on fatty acid metabolism 
Oxygen uptake in substrate-free perfused livers is driven essen- 
tially by the oxidation of endogen ous fatty acids [26]. Since usnic 
acid stimulates oxygen uptake under these condition s, it is of inter- 
est to know whether it also stimulates oxidation of exogenou s fatty 
acids. In the present work this question was investiga ted using the 
14C-labeled forms of a medium- and a long-chain fatty acid, namely 
[1-14C]octanoate and [1- 14C]oleate. Fig. 7 shows the time courses 
of the experiments that were done with 0.2 mM [1- 14C]octanoate
and 10 lM usnic acid. Four paramete rs were measure d: oxygen 
uptake, 14C-production, b-hydroxybu tyrate production and aceto- 
acetate production. Since livers from fasted rats were used, there 
was a signiﬁcant basal production of acetoacetate and b-hydroxy-
butyrate, a fact that corroborates the notion that substrate-free 
perfused livers are oxidizing endogenous fatty acids [26]. The 
introduct ion of [1- 14C]octano ate caused an immediate release of 
14CO2, stimulations of oxygen uptake and b-hydroxybu tyrate pro- 
A B
Fig. 5. Time courses of the effects of 10 lM usnic acid on alanine metabolism. Livers from fasted rats were perfused as described in Section 2. Alanine was infused during 
70 min (10–80 min perfusion time). Usnic acid was infused during 30 min (40–70 min perfusion time). Samples of the efﬂuent perfusion ﬂuid were collected for the 
enzymatic metabolite assay. Oxygen consumption was monitored polarographically. Panel A: parameters linked to the ﬂow of carbon derived from alanine and oxygen 
uptake and panel B: parameters linked to the ﬂow of nitrogen derived from alanine. Each datum point represents the mean of four liver perfusion experiments. Bars are 
standard errors of the mean. 
A B
Fig. 6. Concentration dependences of the changes promoted by usnic acid in alanine metabolism. Livers from fasted rats were perfused as described in the Section 2 and 
according to the experimental protocol illustrated by Fig. 5. The changes promoted by usnic acid after 30 min infusion (70 min perfusion time) were computed. Each datum 
point represents the mean of four liver perfusion experiments. Bars are standard errors of the mean. Panel A: changes produced by usnic acid on the ﬂow of carbon derived 
from alanine metabolism and panel B: changes produced by usnic acid on the ﬂow of nitrogen derived from alanine metabolism. 
C.T. Moreira et al. / Chemico-Biological Interactions 203 (2013) 502–511 507duction and an increase in the b-hydroxybu tyrate to acetoacetate 
ratio. The latter reﬂects the mitochondrial NADH/NAD + ratio due 
to the near equilibriu m of the mitochondr ial b-hydroxybu tyrate dehydrogen ase [27]. The exact values of the metaboli c ﬂuxes are 
listed in Table 1. In this table the productions of b-hydroxybu tyrate 
and acetoacetate were added up and labeled as ketone bodies pro- 
Fig. 7. Time course of the effects of 10 lM usnic acid on octanoate metabolism. 
Livers from fasted rats were perfused as described in the Section 2. [1- 14C]Octa- 
noate (0.2 mM; 1 lCi/l) was infused during 60 min (10–70 min perfusion time).
Usnic acid was infused during 44 min (26–70 min perfusion time). Samples of the 
efﬂuent perfusion ﬂuid were collected for the enzymatic assay of b-hydroxybuty- 
rate and acetoacetate. Oxygen consumption was monitored polarographically. 
14CO2 was trapped in phenylethylamine and measured in a liquid scintillation 
counter. Each datum point represents the mean of four liver perfusion experiments. 
Bars are standard errors of the mean. 
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time led to an increased 14CO2 production and a decreased b-
hydroxybuty rate production (Fig. 7). The pronounced decrease in 
the b-hydroxybu tyrate production also caused a marked decrease 
in the b-hydroxybu tyrate/aceto acetate ratio, a phenomenon that 
was further enhanced by the slight increase in the acetoacetate 
production. Table 1 shows that the actions of usnic acid on octano- 
ate metabolism were concentration- dependent, as the effects of 
2.5 lM usnic acid were less pronounced than those of 10 lM usnic 
acid but always in the same direction for each parameter. It should 
be remarked that usnic acid caused a pronounced inhibition of ke- 
tone bodies production. With 10 lM usnic acid the ketone bodies 
production with octanoate was even 35% smaller than that found 
during substrate-free perfusion. It should equally be remarked that 
usnic acid was without effect on oxygen uptake in the presence of 
0.2 mM octanoate. 
Fig. 8 shows the time courses of the effects of 10 lM usnic acid 
on [1- 14C]oleate metabolism. Table 1 lists the values of the various 
parameters in the absence and presence of 2.5 and 10 lM usnic 
acid. The infusion of [1- 14C]oleate produced changes in all the mea- 
sured parameters that were similar to those found with octanoate: 
stimulation of oxygen uptake and ketone bodies production and 
enhancement of the b-hydroxybu tyrate/aceto acetate ratio. Usnic 
acid did not affect the stimulated oxygen uptake. Also, the ketone 
bodies production was not signiﬁcantly affected by either 2.5 or 
10 lM usnic acid (Table 1). The b-hydroxybutyrate /acetoacetat eratio, however, was diminished by usnic acid, though by a far lesser 
extent when compared to the similar action when octanoate was 
the substrate. The 14CO2 production from [1- 14C]oleate, on the 
other hand, was not affected by 2.5 lM usnic acid and only slightly 
stimulated at the concentratio n of 10 lM.3.6. Effects of usnic acid on adenine mononucleotide contents 
The levels of the adenine mononucleo tides (AMP, ADP and ATP)
were measured in order to obtain informat ion about the energy 
status of the liver in the presence of two different usnic acid con- 
centrations . The measurements were carried out in livers from 
fasted rats in the presence of 2 mM lactate. The results are shown 
in Table 2. Usnic acid decreased the ATP content. This decrease 
reached 61% at the concentration of 10 lM. At this usnic acid con- 
centration both the ADP and AMP contents were signiﬁcantly high- 
er than those in the control condition . The ATP/ADP ratio (an
important regulator y ratio) also dropped considerably . A tendency 
toward lower total mononucleotide contents (AMP + ADP + ATP)
was also observed, but it lacked statistical signiﬁcance at the 5% 
level.4. Discussion 
Several observations of the present work about the action of us- 
nic acid in the perfused liver are compatible with its reported 
uncoupli ng action. The most important of these observati ons, 
which have also been traditionally reported for other uncouplers 
of oxidative phosphoryla tion, are: (a) stimulati on of oxygen con- 
sumption at low concentratio ns [18,28]; (b) diminution of the 
ATP content combined with diminutions in the ATP/ADP and 
ATP/AMP ratios [28]; (c) increase in the cytosolic NADH/NAD + ratio
[18,28]; (d) inhibition of gluconeogenesi s [18,29] from three differ- 
ent substrates, namely lactate, fructose and alanine; (e) stimula- 
tion of glycolysis and fructolysi s as a cytosolic compensator y
phenomeno n for the diminished mitochondrial ATP production 
[18,21,28 ]; (f) stimulati on of glycogenolysis as a means of provid- 
ing glucose 6-phosphat e for the increased glycolytic ﬂux [19,28];
(g) increase in ammonia production combined with impaired urea 
production [21].
All the phenomena listed above are more or less common to 
most uncouplers, a fact that does not exclude the possibility that 
each individual compound with uncoupling action presents its 
own peculiarities. One such peculiarity is the concentr ation range 
between mild and full uncoupli ng, the latter being a highly toxic 
condition . Concerning the concentration range between mild and 
full uncoupli ng, the uncouplers have been recently classiﬁed into 
two different groups [2]. The ﬁrst group comprises those uncou- 
plers which have a wide uncoupli ng range, as for example, 2,6- 
bis(1,1-dimethylethyl)-4-methylphenol (BHT), whose uncoupling 
action occurs between 2  1012 M and 10 6 M. Uncouplers of 
the second group, by contrast, have a relatively narrow uncoupling 
range which hardly extends over more than one order of magni- 
tude. The classical uncoupler 2,4-dinitrophenol belongs to this 
group. Uncouplers with a wide uncoupli ng range are said to be less 
dangerous when used for purposes of weight loss because it is 
much more difﬁcult to attain per accident highly toxic plasma con- 
centrations [2]. In the case of usnic acid, it is clear that it must be 
classiﬁed as a narrow range uncoupler because all the effects that 
are characteristic of uncoupling were found in the concentr ation 
range between 1 and 10 lM. Within this concentratio n range usnic 
acid is in fact a very potent metabolic effector, considerably more 
potent than the classical uncoupler 2,4-dinitrophenol and several 
others. In this respect, comparisons of IC 50 values will be illustra- 
tive. The usnic acid IC 50 values for gluconeogenes is inhibition were 
Table 1
Inﬂuence of usnic acid on the transformation of [1- 14C] octanoate and 1- 14C]oleate in the perfused rat liver. Livers from fasted rats were perfused as described in the Section 2
according to the experimental protocols illustrat ed by Figs. 7 and 8. Basal rates refer to the metabolic rates measured just before the onset of octanoate or oleate infusio n. Rates in 
the presence of the fatty acids but absence of usnic acid refer to the metabolic rates measured just before the onset of usnic acid infusio n. Rates referring to the simultane ous 
presence of the fatty acid and usnic acid were evaluated at the end of the perfusion experiment, as ilustrated by Figs. 7 (octanoate) and 8 (oleate). Ketone bodies production refers 
to the sum of b-hydroxybutyrate (b-Hbut) and acetoac etate (AcAc) productions. Values are means ± SEM. Asterisks (⁄) indicate statistical difference s between the values observed 
in the absence of usnic acid and the values found in the presence of the various usnic acid concentrations (p 6 0.05).
Conditions 14CO2 production (lmol 
min 1g1)
Oxygen consumption (lmol 
min 1g1)
Ketone bodies production (lmol 
min 1g1)
b-Hbut/ 
AcAc 
Basal rates (substrate-free perfusion) – 2.30 ± 0.09 0.43 ± 0.13 0.28 ± 0.03 
0.2 mM Octanoate 0.67 ± 0.02 2.95 ± 0.13 1.27 ± 0.15 2.34 ± 0.40 
0.2 mM Octanoate + 2.5 lM usnic acid 1.13 ± 0.13 ⁄ 2.81 ± 0.15 0.65 ± 0.11 ⁄ 0.10 ± 0.03 ⁄
0.2 mM Octanoate + 10 lM usnic acid 1.34 ± 0.08 ⁄ 2.90 ± 0.14 0.28 ± 0.06 ⁄ 0.12 ± 0.03 ⁄
0.2 mM Oleate 0.58 ± 0.02 2.81 ± 0.20 1.11 ± 0.29 2.13 ± 0.14 
0.2 mM Oleate + 2.5 lM usnic acid 0.57 ± 0.04 2.80 ± 0.16 1.00 ± 0.05 1.78 ± 0.06 
0.2 mM Oleate + 10 lM usnic acid 0.88 ± 0.09 ⁄ 2.81 ± 0.17 0.95 ± 0.23 0.71 ± 0.21 ⁄
Fig. 8. Time course of the effects of 10 lM usnic acid on oleate metabolism. Livers 
from fasted rats were perfused as described in the Section 2. [1- 14C]Oleate (0.2 mM; 
1 lCi/l) was infused during 40 min (10–50 min perfusion time). Usnic acid was 
infused during 30 min (20–50 min perfusion time). Samples of the efﬂuent
perfusion ﬂuid were collected for the enzymatic assay of b-hydroxybutyrate (Hbut)
and acetocetate (AcAc). Oxygen consumption was monitored polarographically. 
14CO2 was trapped in phenylethylamine and measured in a liquid scintillation 
counter. Each datum point represents the mean of four liver perfusion experiments. 
Bars are standard errors of the mean. 
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phenol a value of 17.9 lM has been recently reported [21]. A sim- 
ilar value was reported for juglone (15 lM) another natural 
product which has also been recommend ed for weight loss pur- 
poses [21]. Usnic acid is also much more potent as an inhibitor of 
gluconeogenes is than several antiinﬂammatories with uncoupling 
action, as for example, mefenamic, ﬂufenamic and niﬂumic acid 
whose IC 50 values are 100, 40 and 22 lM, respectively [18,19,29 ].
It is worth at this point to compare the inﬂuence of usnic acid 
on 13C incorporati on into lactate by isolated hepatocytes [13] with
the results found in the present work. Lactate production from endogen ous glycogen in our experiments increased linearly with 
the concentration of usnic acid and stimulation reached 180% at 
the concentratio n of 10 lM. Steady-state conditions were reached 
after 20 min infusion. In isolated hepatocytes a signiﬁcant incorpo- 
ration of 13C into lactate was found only after 24 h, solely with 
5 lM usnic acid and with an increase in incorporation of less than 
15%. Similarly , an inhibition of 13C incorporati on into new glucose 
(gluconeogenesis) occurred only with 10 lM usnic acid and after 
6–24 h. This contrasts sharply with our experiments in which inhi- 
bition of gluconeogenesi s developed rapidly (20 min) and reached 
50% inhibition at concentratio ns between 1.33 and 3.61 lM. These 
comparis ons emphasize the importance of direct measureme nts of 
metaboli c ﬂuxes in a system that is as close as possible to the phys- 
iological conditions. 
Although usnic acid has been used for weight loss purposes [3],
the data obtained in the present work indicate that the drug might 
not be as effective as can be expected from its strong uncoupling 
action. For an uncoupler to be a highly effective promoter of weight 
loss, stimulation of fatty acid oxidation is important. Stimulation of 
fatty acid oxidation requires stimulation of oxygen uptake in the 
mitochondr ial respiratory chain. Although usnic acid in fact stimu- 
lates oxygen consumption in the perfused liver, this effect is not 
very pronounced and even absent under some condition s. Our 
observati ons suggest that there is a narrow limit between the con- 
centrations that stimulate oxygen uptake by means of uncoupling 
and those that inhibit electron ﬂow [10]. A stable increment in oxy- 
gen uptake was found only for usnic acid concentr ations up to 
2.5 lM. At higher concentrations an initial increment was rapidly 
followed by a progressive decrease . This initial incremen t was 
more pronounced during substrate-free perfusion of the liver, i.e., 
when the organ was respiring mainly at the expense of endoge- 
nous fatty acids. In the presence of substrates this initial increment 
was generally smaller or even absent. This phenomenon was espe- 
cially pronounced when the perfusion was carried out in the pres- 
ence of fatty acids. The results of our experiments with the fatty 
acids octanoate and oleate suggest very strongly that usnic acid 
is incapable of increasing oxygen uptake to levels above those al- 
ready attained in the presence of these fatty acids alone. Possibly 
the mitochondrial capacity of shuttling reducing equivalents into 
the respiratory chain is already at its limits when exogenous fatty 
acids are introduce d so that the abolition of the respiratory control 
by an uncoupler has little inﬂuence. This is indeed indicated by the 
very high mitochondrial NADH/NAD + ratio induced by fatty acids, 
especiall y octanoate. On the other hand, the overall effect of usnic 
acid on fatty acid metaboli sm is quite complex as evidenced by a
few observations. The ﬁrst of these observations is that the absence 
of oxygen uptake incremen ts when octanoate and oleate were 
introduce d contrasts with the increased 14CO2 productions that 
were observed, especially when [1- 14C]octanoate was the sub- 
Table 2
Inﬂuence of usnic acid on the hepatic contents of adenine mononucleotide s in the presence of 2 mM lactate. Livers from fasted rats were perfus ed in an open system as described 
in Section 2. The experimental protocol delineated in Fig. 3A was followed with two different usnic acid concentrations. The livers were freeze-clamped in liquid nitrogen at 
70 min perfusion time and the adenine mononucleotides were extrac ted with cold perchloric acid. Control determinations were done with livers that were freeze-clamped at the 
same perfusion time in the presence of lactate but without usnic acid infusion. Values are means ± SEM. Asterisks (⁄) indicate statistical difference s between the control 
experiments and the experiments that were done in the presence of usnic acid (p 6 0.05).
Conditions ATP (lmol/g) ADP (lmol/g) AMP (lmol/g) (AMP + ADP + ATP) (lmol/g) ATP/ADP 
Control (n = 4) 2.40 ± 0.22 0.74 ± 0.04 0.41 ± 0.10 3.55 ± 0.34 3.24 ± 0.22 
5 lM usnic acid (n = 4) 1.56 ± 0.15 ⁄ 0.88 ± 0.01 0.50 ± 0.03 2.94 ± 0.13 1.78 ± 0.18 ⁄
10 lM usnic acid (n = 4) 0.74 ± 0.13 ⁄ 1.23 ± 0.07 ⁄ 0.82 ± 0.13 ⁄ 2.79 ± 0.25 0.62 ± 0.10 ⁄
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increased 14CO2 production/no oxygen uptake increment, is that 
usnic acid could be further enhancing the preference of the liver 
cells for oxidizing exogenous fatty acids in detriment to endoge- 
nous ones. This explanation works very well for oleate, but less 
well for octanoate, because in the latter case stimulation of 14CO2
production was more pronounced and coupled to a clear inhibition 
of ketone bodies production. This observati on suggests that usnic 
acid affects differently the transformat ion of medium- and long- 
chain fatty acids. It can even be suggested that usnic acid causes 
a speciﬁc inhibition of octanoate transformat ion because no inhibi- 
tion of ketone bodies production was found with oleate. The fact 
that the 14CO2 production from octanoate was stimulated does 
not disprove this possibility. An increased 14CO2 production does 
not necessarily imply in an increased rate of fatty acid oxidation 
because the endogenous fatty acids are not 14C-labeled. Further- 
more, the increased 14CO2 production can also partly reﬂect an in- 
creased activity of the tricarboxylic acid cycle which is the 
preferred route for the transformat ion of the carbon units of acet- 
yl-CoA when compared to ketogene sis [30]. The latter phenome- 
non generally occurs when the mitochondrial NADH/NAD + radio
is decreased, as indicated by the b-hydroxybu tyrate/acetoaceta te 
ratio [27]. In this respect it is worth to emphasize that usnic acid 
decreases the b-hydroxybu tyrate/acetoacete ratio to a much great- 
er extent in the presence of octanoate than in the presence of ole- 
ate, again strongly suggesting speciﬁc effects on octanoate 
metabolism that go beyond the simple uncoupling action. 
General toxicity and hepatoto xicity of usnic acid [3,16,17] is
fully corrobor ated by several observations of the present work. In 
addition to ATP depletion, which had already been reported previ- 
ously [12,13], there are other aspects which have not yet been de- 
scribed. One of these points is the strong inhibition of ureagenesis 
(IC50 = 2.69 lM), combined with the compara bly strong inhibition 
of gluconeo genesis (IC50 between 1.33 and 3.61 lM). The classical 
uncoupler 2,4-dinitrop henol, while inhibiting gluconeo genesis 
(IC50 = 17.9 lM), actually stimulates urea production at concentra- 
tions up to 50 lM with half-maximal stimulati on at 4.76 lM [21].
Juglone, the natural uncoupler found in the walnut, begins to inhi- 
bit urea production at concentrations higher than 20 lM. At con- 
centrations up to 20 lM it is stimulatory [21]. These comparisons 
reveal a combination of effects for usnic acid that is much more 
harmful when compare d to the classical uncoupler 2,4-dinitrophe- 
nol, namely a strong inhibition of both gluconeogenesi s and 
ammonia detoxiﬁcation within a very short concentration range. 
Particularly in the fasted state one can predict that the ingestion 
of usnic can be especially harmful. Under this metabolic condition 
the glucose supply to the nervous tissue depends basically on he- 
patic gluconeo genesis, which will be strongly inhibited by usnic 
acid. This limitation may occur in combination with a shortage in 
the supply of ketone bodies, an alternative carbon source for the 
brain, since usnic acid has been found to limit or even to inhibit 
ketogenesis depending on the conditions. 
In conclusion, usnic acid exerts numerous metabolic effects that 
tend, in principle at least, to be harmful to the organism. It is true 
that there are serious claims that mild uncoupling can be beneﬁcialfor health. Mild uncoupling seems to trigger molecular mecha- 
nisms that are able to increase the expression of mitochondrial 
genes [31] and it has also been claimed that it increases longevity 
in mice associate d with the improvement of several serological 
markers [32]. In the case of usnic acid, however , it seems that 
the very narrow concentration range of its action makes it very dif- 
ﬁcult to adjust the ingested doses in such a way as to avoid toxic 
and harmful manifest ations. Conﬂict of interest statement 
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